Lao news and features

Two new vaccines that help protect against cervical cancer, measles and rubella spearhead the GAVI Alliance’s commitment to improving the health of girls and women.

Kenya becomes the first country to protect girls against cervical cancer with GAVI-supported human papillomavirus (HPV) vaccines.

Historic agreements show power of innovative public-private partnership

More than 180,000 girls in eight developing countries are set to receive protection against the leading cause of cervical cancer thanks to human papillomavirus (HPV) vaccines funded by the GAVI Alliance.

In November 2011, Laos is introducing rubella vaccine for the first time. During a two-phase campaign, Laos plans to immunise more than three million young people with the combined vaccine for measles and rubella ("MR" vaccine), offering protection against two preventable diseases.

Immunization at the global level has progressed very well during the past 25 years, but further increases in coverage would save the lives of millions more who do not yet benefit from this protection, said a group of immunization partners at the World Vaccine Congress in Lyon, France.